Coronary artery anomalies: what are they? when to suspect? how to treat?-a narrative review

被引:0
|
作者
Evangelista, Martina [1 ]
Ferrero, Paolo [1 ]
D'Aiello, Angelo Fabio [1 ]
Negura, Diana [1 ]
Micheletti, Angelo [1 ]
Bevilacqua, Francesca [1 ]
Pasqualin, Giulia [1 ]
Chessa, Massimo [1 ,2 ]
机构
[1] IRCCS Policlin San Donato, Pediat & Adult Congenital Heart Ctr, ACHD Unit, Piazza Edmondo Malan 2, I-20097 Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
关键词
Anomalous coronary artery; coronary anomaly; sudden cardiac death (SCD); congenital heart disease; myocardial dysfunction; EMISSION COMPUTED-TOMOGRAPHY; PULMONARY-ARTERY; AORTIC ORIGIN; SUDDEN-DEATH; MAGNETIC-RESONANCE; OPPOSITE SINUS; MYOCARDIAL-PERFUSION; ALCAPA SYNDROME; REPAIR; DIAGNOSIS;
D O I
10.21037/tp-24-30
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background and Objective: In the literature have been widely discussed different classification criteria for coronary artery anomalies (CAAs), some authors have tried to categorize them only as "major" or "hemodynamically significant" anomalies versus "minor" or "not hemodynamically significant" ones. However, the most recent literature has concluded that all possible coronary anatomy should be taken into consideration in a comprehensive classification of CAAs. The aim of the article is to review the most recent literature regarding CAAs to provide a comprehensive overview of this challenging topic. Methods: We propose a narrative overview of the most impactful and recent literature, synthetizing and reelaborating the most important articles concerning CAAs. Key Content and Findings: The important gap of knowledge on the specific characteristics of CAAs has led to a progressively increased interest of the current research in this field. Albeit their nature is still unclear, an increased awareness of their fatality is spreading among clinicians and the general population, mostly associated with their clinical relevance among young patients and athletes. On the other side, we do believe that clinical and hemodynamic repercussions are of crucial importance and should always be integrated to understand the true nature of this important pathology. Conclusions: In the field of pediatric cardiology, CAAs are one of the most fascinating and studied subject. We propose a state-of-the art review to provide a comprehensive and systematic description and subsequently an approach to the epidemiological, pathophysiological, and clinical aspects of the most important CAAs in the pediatric population.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Osteoporosis: Who, when, how long to treat, and with what effectiveness?
    Kanis, JA
    DRUG INFORMATION JOURNAL, 1999, 33 (01): : 315 - 319
  • [32] Neonatal seizures. Treat! But when, with what and for how long?
    Hunt, Rod
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2023, 108 (06): : F552 - F553
  • [33] WHO TO TREAT, WHEN TO START, WHAT DRUG AND HOW LONG
    Sambrook, P.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S659 - S659
  • [34] How long to treat and what to do when you stop?
    Ferrari, Serge
    BONE, 2010, 46 : S17 - S17
  • [35] Endophthalmitis in immune compromised patients - what, when and how to treat?
    Saunte, J. P.
    la Cour, M.
    Villumsen, J.
    ACTA OPHTHALMOLOGICA, 2008, 86 : 52 - 52
  • [36] Anomalous Left Coronary Artery from the Pulmonary Artery: How to Diagnose and Treat
    Blickenstaff, Elaina A.
    Smith, Sean D.
    Cetta, Frank
    Connolly, Heidi M.
    Majdalany, David S.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (11):
  • [37] Narrative review of pelvic floor muscle training for childbearing women—why, when, what, and how
    Stephanie J. Woodley
    E. Jean C. Hay-Smith
    International Urogynecology Journal, 2021, 32 : 1977 - 1988
  • [38] Reimagining How We Treat Acute Pain: A Narrative Review
    Castroman, Pablo
    Quiroga, Ovelio
    Rojals, Victor Mayoral
    Gomez, Maria
    Moka, Eleni
    Pergolizzi, Joseph, Jr.
    Varrassi, Giustino
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [39] How should I treat severe coronary artery calcification when it is not possible to dilate a balloon or deliver a RotaWire™?
    McKenzie, Daniel B.
    Talwar, Suneel
    Jokhi, Percy P.
    O'Kane, Peter D.
    EUROINTERVENTION, 2011, 6 (06) : 779 - 780
  • [40] Pharmacogenomic biomarkers in coronary artery disease: a narrative review
    Dua, Pamila
    Seth, Sandeep
    Prasher, Bhavana
    Mukerji, Mitali
    Maulik, Subir Kumar
    Reeta, K. H.
    BIOMARKERS IN MEDICINE, 2024, 18 (05) : 191 - 202